ENTITY

Tissue Regenix (LSW GR)

8
Analysis
Health Care • United Kingdom
Tissue Regenix Group is an international medical technology company specializing in regenerative products using its dCELL® and BioRinse™ platform technologies. These technologies address soft tissue and bone allograft needs through products like DermaPure® for soft tissue repair and ConCelltrate® for bone regeneration, primarily serving the BioSurgery, Orthopaedics, and Dental markets. The company was founded in 2006 in Leeds, UK, and has operations in the UK and US.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x